Journal article icon

Journal article

GliMR: Cross-Border Collaborations to Promote Advanced MRI Biomarkers for Glioma

Abstract:
Abstract Purpose There is an annual incidence of 50,000 glioma cases in Europe. The optimal treatment strategy is highly personalised, depending on tumour type, grade, spatial localization, and the degree of tissue infiltration. In research settings, advanced magnetic resonance imaging (MRI) has shown great promise as a tool to inform personalised treatment decisions. However, the use of advanced MRI in clinical practice remains scarce due to the downstream effects of siloed glioma imaging research with limited representation of MRI specialists in established consortia; and the associated lack of available tools and expertise in clinical settings. These shortcomings delay the translation of scientific breakthroughs into novel treatment strategy. As a response we have developed the network “Glioma MR Imaging 2.0” (GliMR) which we present in this article. Methods GliMR aims to build a pan-European and multidisciplinary network of experts and accelerate the use of advanced MRI in glioma beyond the current “state-of-the-art” in glioma imaging. The Action Glioma MR Imaging 2.0 (GliMR) was granted funding by the European Cooperation in Science and Technology (COST) in June 2019. Results GliMR’s first grant period ran from September 2019 to April 2020, during which several meetings were held and projects were initiated, such as reviewing the current knowledge on advanced MRI; developing a General Data Protection Regulation (GDPR) compliant consent form; and setting up the website. Conclusion The Action overcomes the pre-existing limitations of glioma research and is funded until September 2023. New members will be accepted during its entire duration.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1007/s40846-020-00582-z

Authors

More by this author
Role:
Author
ORCID:
0000-0001-8546-0134
More by this author
Role:
Author
ORCID:
0000-0003-0984-3998
More by this author
Role:
Author
ORCID:
0000-0002-5178-7929
More by this author
Role:
Author
ORCID:
0000-0002-6580-9519
More by this author
Role:
Author
ORCID:
0000-0002-0743-0869


More from this funder
Funder identifier:
10.13039/501100000921
Grant:
CA18206


Publisher:
Springer
Journal:
Journal of Medical and Biological Engineering More from this journal
Volume:
41
Issue:
2
Pages:
115-125
Publication date:
2020-12-03
DOI:
EISSN:
2199-4757
ISSN:
1609-0985


Language:
English
Keywords:
Pubs id:
1949531
Local pid:
pubs:1949531
Source identifiers:
W3110120876
Deposit date:
2026-06-10
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP